Rempex Pharmaceuticals Lands $67,500,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8154feb5-eb19-41d2-9011-f61b15b6c79e&Preview=1 -
Date
11/9/2011 -
Company Name
Rempex Pharmaceuticals -
Mailing Address
11535 Sorrento Valley Rd. San Diego, CA 92121 -
Company Description
Rempex Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. -
Website
http://www.rempexpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$67,500,000 -
Transaction Round
Series B -
Proceeds Purposes
This financing gives us the resources to rapidly advance our development programs towards commercialization at a time when the need for new treatments for resistant gram-negative infections has become critical. -
M&A Terms
-
Venture Investor
Frazier Healthcare Ventures -
Venture Investor
Vivo Ventures -
Venture Investor
SV Life Sciences -
Venture Investor
OrbiMed -
Venture Investor
Adams Street Partners
